Medigene with strong impulseIs medigene breaking out of trendchannel or simply overbought right now. CRS and RSI strong.
Came out of a bollinger squeeze and rising.
How can you tell if its a breakout from trend? Will it continue or fall back?
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.2320 EUR
−16.18 M EUR
6.03 M EUR
6.92 M
About MEDIGENE AG
Sector
Industry
CEO
Selwyn Ho
Website
Headquarters
Martinsried
Founded
1996
ISIN
DE000A40ESG2
FIGI
BBG00NRVXVH8
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0QGJ is 1.7000 EUR — it has decreased by −10.57% in the past 24 hours. Watch MEDIGENE AG NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MEDIGENE AG NPV stocks are traded under the ticker 0QGJ.
0QGJ stock has fallen by −10.57% compared to the previous week, the month change is a −18.97% fall, over the last year MEDIGENE AG NPV has showed a −41.41% decrease.
We've gathered analysts' opinions on MEDIGENE AG NPV future price: according to them, 0QGJ price has a max estimate of 6.00 EUR and a min estimate of 6.00 EUR. Watch 0QGJ chart and read a more detailed MEDIGENE AG NPV stock forecast: see what analysts think of MEDIGENE AG NPV and suggest that you do with its stocks.
0QGJ reached its all-time high on Apr 8, 2019 with the price of 19.0904 EUR, and its all-time low was 1.7220 EUR and was reached on Oct 28, 2024. View more price dynamics on 0QGJ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0QGJ stock is 1.53% volatile and has beta coefficient of 0.77. Track MEDIGENE AG NPV stock price on the chart and check out the list of the most volatile stocks — is MEDIGENE AG NPV there?
Today MEDIGENE AG NPV has the market capitalization of 11.91 M, it has decreased by −11.18% over the last week.
Yes, you can track MEDIGENE AG NPV financials in yearly and quarterly reports right on TradingView.
MEDIGENE AG NPV is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
0QGJ earnings for the last half-year are −0.52 EUR per share, whereas the estimation was −0.56 EUR, resulting in a 7.14% surprise. The estimated earnings for the next half-year are −0.38 EUR per share. See more details about MEDIGENE AG NPV earnings.
MEDIGENE AG NPV revenue for the last half-year amounts to 4.48 M EUR, despite the estimated figure of 4.15 M EUR. In the next half-year revenue is expected to reach 6.52 M EUR.
0QGJ net income for the last half-year is −6.73 M EUR, while the previous report showed −9.21 M EUR of net income which accounts for 26.95% change. Track more MEDIGENE AG NPV financial stats to get the full picture.
No, 0QGJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 86.00 employees. See our rating of the largest employees — is MEDIGENE AG NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGENE AG NPV EBITDA is −14.26 M EUR, and current EBITDA margin is −249.04%. See more stats in MEDIGENE AG NPV financial statements.
Like other stocks, 0QGJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGENE AG NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIGENE AG NPV technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIGENE AG NPV stock shows the sell signal. See more of MEDIGENE AG NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.